Jones T, Moura AF, Alrjoub W, Amdal CD, Giesinger JM, Gilbert A, Groenvold M, Hamzeh H, Iyizoba Z, Koller M, Kuliś D, Lai-Kwon J, Musoro J, Pe M, Petersen MA, Shamieh O, Velikova G, Zeman F, Piccinin C, Nolte S, EORTC Quality of Life Group (2026)
Single-item measures of perceived side effect burden for people with cancer: A systematic scoping review
Eur J Cancer, 248, 117763 (in press)
DOI 10.1016/j.ejca.2026.117763, PubMed 42843209

Dillard P, Köksal H, Maggadottir SM, Winge-Main A, Pollmann S, Menard M, Myhre MR, Mælandsmo GM, Flørenes VA, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2026)
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
Mol Ther (in press)
DOI 10.1016/j.ymthe.2026.09.027, PubMed 42800469

Hofsø K, Rustøen T, Bjordal K, Hagen M, Aouizerat B, Astrup GL (2026)
Association between symptom experience and long-term survival in people treated for cancer
ESMO Open, 11 (10), 108579 (in press)
DOI 10.1016/j.esmoop.2026.108579, PubMed 42767083